Table 3. Demographics for evaluable patients (N=36).

Variable	N (%)
Age at primary diagnosis (yrs), median (range)	50 (24-74)
Sex
Male	10 (28%)
Female	26 (72%)
Median KPS	90 (80-100)
Tumor Types
Breast	24 (67%)
Prostate	3 (8%)
Others	9 (25%)
TCC Bladder	2
TCC Ureter	1
Adrenocortical carcinoma	1
Leiomyosarcoma	1
Melanoma	1
NSCLC	1
Squamous cell of Tongue	1
Colon	1
Lines of prior chemotherapy in metastatic setting, median (range)	2 (0-7)
Duration of HSP90 inhibitor therapy (days), median (range)	55 (16-411)